A PHASE II, OPEN-LABEL, MULTICENTER,RANDOMIZED STUDY OF THE EFFICACY AND
SAFETY OF RO7198457 IN COMBINATION WITH PEMBROLIZUMAB VERSUS PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED
ADVANCED MELANOMA

IRB/UVA Tracking #
21885
Contact
Adela Mahmutovic, Adela Mahmutovic
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Varinder Kaur
Status
OPEN TO ACCRUAL
Ages
Adult